Quoin Pharmaceuticals Ltd. (QNRX) stock
QNRXNasdaqPharmaceutical Preparations
$3.56+0.20 (+5.95%)
Close on Nov 18, 2026Market cap $7.15MP/E –Yield –
Quoin Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Quoin Pharmaceuticals's cash was $10.80M at Jun 30, 2026. For fiscal 2025 it was $18.75M, up 33.4% from the year before. Over ten years it grew 33.8% a year on average. The highest annual figure on record is $18.75M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.75M | +33.4% |
| FY2024 | Dec 31, 2024 | $14.06M | +485.4% |
| FY2023 | Dec 31, 2023 | $2.40M | -16.1% |
| FY2022 | Dec 31, 2022 | $2.86M | -61.8% |
| FY2021 | Dec 31, 2021 | $7.48M | +2210.7% |
| FY2020 | Dec 31, 2020 | $323.83K | -94.3% |
| FY2019 | Dec 31, 2019 | $5.63M | +14079900.0% |
| FY2018 | Dec 31, 2018 | $40 | -100.0% |
| FY2017 | Dec 31, 2017 | $3.76M | +109.5% |
| FY2016 | Dec 31, 2016 | $1.80M | +76.4% |
| FY2015 | Dec 31, 2015 | $1.02M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $10.80M | +547.3% |
| Q1 FY2026 | Mar 31, 2026 | $14.04M | +267.4% |
| Q4 FY2025 | Dec 31, 2025 | $18.75M | +33.4% |
| Q3 FY2025 | Sep 30, 2025 | $1.83M | -41.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.67M | -41.4% |
| Q1 FY2025 | Mar 31, 2025 | $3.82M | +108.5% |
| Q4 FY2024 | Dec 31, 2024 | $14.06M | +485.4% |
| Q3 FY2024 | Sep 30, 2024 | $3.12M | -1.5% |
| Q2 FY2024 | Jun 30, 2024 | $2.85M | -40.2% |
| Q1 FY2024 | Mar 31, 2024 | $1.83M | -45.6% |
| Q4 FY2023 | Dec 31, 2023 | $2.40M | -16.1% |
| Q3 FY2023 | Sep 30, 2023 | $3.16M | -39.7% |
| Q2 FY2023 | Jun 30, 2023 | $4.76M | +77.1% |
| Q1 FY2023 | Mar 31, 2023 | $3.37M | -35.0% |
| Q4 FY2022 | Dec 31, 2022 | $2.86M | -61.8% |
| Q3 FY2022 | Sep 30, 2022 | $5.25M | +704.2% |
| Q2 FY2022 | Jun 30, 2022 | $2.69M | +56.2% |
| Q1 FY2022 | Mar 31, 2022 | $5.19M | +1502.4% |
| Q4 FY2021 | Dec 31, 2021 | $7.48M | +32.9% |
| Q3 FY2021 | Sep 30, 2021 | $652.79K | +1631880.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.72M | -69.8% |
| Q4 FY2020 | Dec 31, 2020 | $323.83K | -91.4% |
| Q4 FY2019 | Dec 31, 2019 | $5.63M | +213.6% |
| Q4 FY2018 | Dec 31, 2018 | $40 | -100.0% |
| Q2 FY2018 | Jun 30, 2018 | $5.71M | – |
| Q4 FY2017 | Dec 31, 2017 | $3.76M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.80M | – |
| Q4 FY2015 | Dec 31, 2015 | $1.02M | – |
See a number that looks wrong?